Fate Therapeutics grants new-hire inducement equity awards, including 37,300 options at $2.45
FATE•Vesting terms
The options vest over four years: 25% after one year, then monthly over the following 36 months.
The RSUs vest over four years in 25% annual installments, subject to continued employment.
Inducement awards to new hires
Fate Therapeutics disclosed August 1, 2026 inducement equity awards to newly hired non-executive employees.
The company granted non-qualified stock options for 37,300 shares at an exercise price of $2.45, set at the July 31 close.
Fate Therapeutics also awarded restricted stock units covering 45,300 shares to two hires, including the option recipient.
